Press Release
CRISPR Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today announced that Rodger Novak, M.D., Chief Executive Officer and Founder of CRISPR Therapeutics, will present at the 28th Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016 at the Lotte New York Palace Hotel, New York.
Event: 28th Annual Piper Jaffray Healthcare Conference
Date: Wednesday, November 30, 2016
Time: 1:30 PM ET
About CRISPR Therapeutics
CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.
MEDIA CONTACTS: Jennifer PaganelliW2O Group for CRISPR 347-658-8290 jpaganelli@w2ogroup.com INVESTOR CONTACT: Chris BrinzeyWestwicke Partners for CRISPR 339-970-2843 chris.brinzey@westwicke.com
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.